about
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trialThe employee absenteeism costs of inflammatory bowel disease: evidence from US National Survey Data.Physician decision making and trends in the use of cardiac stress testing in the United States: an analysis of repeated cross-sectional data.The Employee Absenteeism Costs of Rheumatoid Arthritis: Evidence From US National Survey Data.Comparison of the clinical and economic outcomes between open and minimally invasive appendectomy and colectomy: evidence from a large commercial payer databaseCommunity-based settings and sampling strategies: implications for reducing racial health disparities among black men, New York City, 2010-2013.Mutations associated with base excision repair deficiency and methylation-induced genotoxic stressTobacco use and smoking intentions among U.S. fifth-grade students.Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery disease.Long-term outcomes of enhanced depression treatment in patients with acute coronary syndromes.Adenosine-stress cardiac magnetic resonance imaging in suspected coronary artery disease: a net cost analysis and reimbursement implications.Emergency department visits for heart failure and subsequent hospitalization or observation unit admission.Use of Preoperative Testing and Physicians' Response to Professional Society Guidance.Projected morbidity and mortality from missed diagnoses of coronary artery disease in the United States.Cost of talking parents, healthy teens: a worksite-based intervention to promote parent-adolescent sexual health communication.Cost and Cost-Effectiveness of Students for Nutrition and eXercise (SNaX)Cost-effectiveness of enhanced depression care after acute coronary syndrome: results from the Coronary Psychosocial Evaluation Studies randomized controlled trialThe Impact of an Online Crowdsourcing Diagnostic Tool on Health Care Utilization: A Case Study Using a Novel Approach to Retrospective Claims Analysis.Observation Units as Substitutes for Hospitalization or Home Discharge.Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease.Clinical implications of referral bias in the diagnostic performance of exercise testing for coronary artery disease.A blood-based gene expression test for obstructive coronary artery disease tested in symptomatic nondiabetic patients referred for myocardial perfusion imaging the COMPASS study.Allergic Reactions in Hospitalized Patients With a Self-Reported Penicillin Allergy Who Receive a Cephalosporin or Meropenem.Underuse of Prevention and Lifestyle Counseling in Patients With Peripheral Artery Disease.External validation of models for estimating pretest probability of coronary artery disease among individuals undergoing myocardial perfusion imaging.Firearm Ownership and Acquisition Among Parents With Risk Factors for Self-Harm or Other Violence.Health Care Utilization and Expenditures Associated With Remote Monitoring in Patients With Implantable Cardiac Devices.Smoking-Cessation Interventions for Urban Hospital Patients: A Randomized Comparative Effectiveness Trial.Use of a blood test incorporating age, sex, and gene expression influences medical decision-making in the evaluation of women presenting with symptoms suggestive of obstructive coronary artery disease: summary results from two ambulatory care studieAssociation of Patient Beliefs and Preferences With Subsequent Testing After Initial Evaluation for Ischemic Heart DiseasePaying Smokers to Quit: Does It Work? Should We Do It?Open access to economic outcome data will help to bridge the gap between clinical trials and clinical guidelines.Open abdominal versus laparoscopic and vaginal hysterectomy: analysis of a large United States payer measuring quality and cost of care.Do black patients with chronic kidney disease benefit equally from all blood pressure lowering agents?Evaluation for coronary artery disease and medicare spending.Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis.Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction.The direct healthcare insurer and out-of-pocket expenditures of psoriasis: evidence from a United States national survey.Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain.Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain.
P50
Q30540634-75FC190B-CF81-4637-AA21-42BE96F3E96BQ30581147-3A620812-FA37-4AD3-BD1E-4707FE6CB1C1Q30857608-AF80BA9E-9B92-4CE4-A033-E622B895F54FQ30967828-0B161B51-6877-4B4E-BA3F-7C010B2E7C29Q33756354-695F03F8-3966-4591-9F7A-898D225F664BQ33796904-EC5B4D59-068E-416D-994A-BBC6DEFD2EC1Q34067688-1CA95127-FBBE-4739-8B7A-612A260C026FQ34084449-8D5ACC1B-AEEE-4BE8-9E54-8B7BB204091FQ34171768-3FAF6EB6-C763-4C37-8DDA-2C2F3FC2D660Q34345168-28FBF014-EFD7-4F26-AD1C-010E2973E5FDQ34561312-C480F20A-4946-4DA0-B60C-2E8CA830E763Q34625322-99411466-DF7B-459D-8806-48E18C861D0EQ35919621-6B237C24-C6C9-4163-9921-EB310A6E4503Q35919631-1B276EC0-EE6F-45AF-A2A9-1211C4A63BBCQ35962219-4A1F93B8-284F-4A06-A67B-0B2CD471269EQ36731027-42FCB46D-CBE5-44B0-B5A8-F854F24A8C59Q36854111-7CE3B4BB-0507-4220-98AB-6383F355E783Q37010164-8F901F9D-C2EB-41EA-9693-A4DA7AA530EEQ37158282-52174E7F-7A2B-42FD-808A-1E4745D202C9Q37434598-90B940CE-8E53-4E6B-A870-5C704A2555B8Q37457740-E05EC7BD-D2E9-476D-A599-366BD466AAC3Q38455885-39ED2A1F-EA5E-45E3-AC60-635A1815E568Q38514140-6F63EF36-F840-4F54-8CD1-401F1901B8B9Q38803492-041AA824-4B5B-4385-BDDE-A5DC075D9CBFQ39041589-6B17F5BF-6148-48B5-81EF-9F9D731626D1Q39593315-9AC1AE5B-1C00-45E2-B1CD-22491D7BCB71Q39903720-FA653295-5242-4645-9A6F-FC54729B6277Q40406226-E600B186-DEA3-4C2B-8CB6-0A7DA18D4A9DQ41132434-94D9410F-F938-460B-BDBA-F6A03B7BB224Q41190274-FD873A2A-9A5F-47C1-9CCB-83E1D23A717DQ42369029-5456EEC5-BB44-4633-AA43-EF2ED437835AQ42628352-258903A6-2AB4-4ACB-8E4D-B18E8AA7081CQ42636856-428EC314-78D7-4DDA-834C-24ACF87C2105Q43119239-F8A84534-C99B-4086-AD36-5DE638D04C82Q43924232-E6CE20DD-7654-4472-96E4-166F09FEA811Q44258281-E5A8A703-F2E0-4117-9686-E63EF0ACD3FCQ44429150-097AF98E-F51D-4FA1-8D7E-77CBB8CF97B8Q44647501-0EEBAC5D-B17B-420F-8C90-211D6A20C599Q44916928-B1AAD600-19FD-466A-BBF6-73F0452DE475Q45765678-101B0BDE-4E1E-4B56-882A-A5E7F13BDF8F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joseph A Ladapo
@ast
Joseph A Ladapo
@en
Joseph A Ladapo
@es
Joseph A Ladapo
@nl
Joseph A Ladapo
@sl
type
label
Joseph A Ladapo
@ast
Joseph A Ladapo
@en
Joseph A Ladapo
@es
Joseph A Ladapo
@nl
Joseph A Ladapo
@sl
prefLabel
Joseph A Ladapo
@ast
Joseph A Ladapo
@en
Joseph A Ladapo
@es
Joseph A Ladapo
@nl
Joseph A Ladapo
@sl
P106
P21
P31
P496
0000-0002-8518-4800